DisclosurePeptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Research summary · not a treatment plan
BPC-157
BPC-157 Gut Healing & Tissue Repair
- US pathway
- Awaiting FDA
- Studied for
- recovery
- Route
- subcutaneous
01
Dosing as studied
250–500 mcg SQ, 1–2x daily. Titrate from lower dose.
02
Cycle length
4–6 weeks on, 2 weeks off
03
Contraindications
Active cancer, pregnancy/nursing. Caution with anticoagulants.
04
Notes
Derived from gastric juice protein with strong preclinical repair data.
05
Regulatory status
The Peptide Association does not endorse or recommend any specific treatment protocol. This page summarizes how BPC-157 has been used and studied. Whether it is right for you, and at what dose, is a decision for a licensed clinician.
BPC-157 is not FDA-approved, and as of October 2026 FDA has not finalized whether pharmacies may compound it.
This protocol is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide therapy.